Kumar Sharma
#144,752
Most Influential Person Now
Researcher
Kumar Sharma's AcademicInfluence.com Rankings
Kumar Sharmacomputer-science Degrees
Computer Science
#7186
World Rank
#7566
Historical Rank
Computational Linguistics
#1390
World Rank
#1405
Historical Rank
Machine Learning
#2578
World Rank
#2612
Historical Rank
Artificial Intelligence
#2870
World Rank
#2914
Historical Rank
Download Badge
Computer Science
Why Is Kumar Sharma Influential?
(Suggest an Edit or Addition)Kumar Sharma's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. (2008) (1131)
- Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. (2000) (928)
- Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development (2014) (857)
- Mouse models of diabetic nephropathy. (2009) (853)
- Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice (1996) (615)
- Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. (1994) (615)
- Hyperglycemia and Diabetic Kidney Disease: The Case for Transforming Growth Factor–β as a Key Mediator (1995) (606)
- Adiponectin regulates albuminuria and podocyte function in mice. (2008) (591)
- The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight (2019) (491)
- Diabetic kidney disease in the db/db mouse. (2003) (456)
- Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. (2013) (429)
- AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. (2013) (368)
- High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β (1992) (348)
- Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK. (2010) (318)
- Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications. (2009) (313)
- Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. (2013) (312)
- Diabetic kidney disease (2015) (303)
- Diabetic kidney disease (2015) (291)
- Increased Renal Production of Transforming Growth Factor-β1 in Patients with Type II Diabetes (1997) (283)
- The emerging role of transforming growth factor-beta in kidney diseases. (1994) (276)
- Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. (1997) (265)
- Pirfenidone for diabetic nephropathy. (2011) (245)
- Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. (1994) (212)
- Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent (2011) (207)
- AMPK mediates the initiation of kidney disease induced by a high-fat diet. (2011) (200)
- Multiple Metabolic Hits Converge on CD36 as Novel Mediator of Tubular Epithelial Apoptosis in Diabetic Nephropathy (2005) (195)
- Utility of endogenous creatinine clearance as a measure of renal function in mice. (2004) (184)
- Severity and Frequency of Proximal Tubule Injury Determines Renal Prognosis. (2016) (173)
- Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. (1999) (170)
- Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. (1998) (166)
- Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. (2016) (162)
- The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. (2005) (160)
- Pirfenidone is renoprotective in diabetic kidney disease. (2009) (159)
- Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. (1995) (157)
- Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury. (2014) (157)
- The link between obesity and albuminuria: adiponectin and podocyte dysfunction. (2009) (156)
- Reactive oxygen species production via NADPH oxidase mediates TGF-beta-induced cytoskeletal alterations in endothelial cells. (2005) (156)
- Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease. (2015) (153)
- Mitochondrial Hormesis and Diabetic Complications (2015) (153)
- Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. (2004) (153)
- Transcription factors in the pathogenesis of diabetic nephropathy (2009) (148)
- Fisetin Lowers Methylglyoxal Dependent Protein Glycation and Limits the Complications of Diabetes (2011) (144)
- Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease. (2016) (132)
- A simplified method for HPLC determination of creatinine in mouse serum. (2004) (131)
- Novel targets of antifibrotic and anti-inflammatory treatment in CKD (2014) (127)
- Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA‐T2D trial (2017) (126)
- Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. (2001) (126)
- The endoplasmic reticulum stress response and diabetic kidney disease. (2011) (126)
- Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. (1995) (126)
- Two‐dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy (2005) (124)
- Kidney disease and obesity: epidemiology, mechanisms and treatment (2017) (124)
- Isoform- and Species-specific Control of Inositol 1,4,5-Trisphosphate (IP3) Receptors by Reactive Oxygen Species* (2014) (121)
- New pharmacological treatments for improving renal outcomes in diabetes (2010) (119)
- Sex-Related Disparities in CKD Progression. (2018) (116)
- Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels. (2002) (114)
- Selective role for superoxide in InsP3 receptor–mediated mitochondrial dysfunction and endothelial apoptosis (2005) (113)
- Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice. (2009) (111)
- Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test. (2005) (111)
- Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. (1997) (110)
- Mouse models of diabetic nephropathy. (2005) (107)
- Obesity related kidney disease. (2011) (103)
- Obesity, oxidative stress, and fibrosis in chronic kidney disease (2014) (102)
- Obstructive Sleep Apnea and Kidney Disease: A Potential Bidirectional Relationship? (2015) (98)
- Nitrative Inactivation of Thioredoxin-1 and Its Role in Postischemic Myocardial Apoptosis (2006) (98)
- Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway (2016) (96)
- Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment. (2007) (94)
- A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. (2012) (94)
- Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells. (2003) (93)
- Overview: combating diabetic nephropathy. (2003) (89)
- TGF-β impairs renal autoregulation via generation of ROS (2005) (89)
- Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients (2017) (88)
- Glycemic control in diabetic CKD patients: where do we stand? (2008) (88)
- TGF-β in diabetic kidney disease: role of novel signaling pathways (2000) (82)
- Mass Spectrometry Imaging Reveals Elevated Glomerular ATP/AMP in Diabetes/obesity and Identifies Sphingomyelin as a Possible Mediator (2016) (80)
- Role of Nox2 in diabetic kidney disease. (2013) (80)
- Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus. (2009) (78)
- Klotho suppresses renal tubulo‐interstitial fibrosis by controlling basic fibroblast growth factor‐2 signalling (2014) (78)
- Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney. (2016) (75)
- Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis (2015) (74)
- Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes. (2010) (74)
- TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1. (2010) (74)
- Role of upstream stimulatory factors in regulation of renal transforming growth factor-beta1. (2005) (72)
- Decorin deficiency enhances progressive nephropathy in diabetic mice. (2007) (72)
- Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease. (2016) (69)
- High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. (1992) (68)
- The transforming growth factor-beta system and the kidney. (1993) (68)
- The Role of Mitochondria in Diabetic Kidney Disease (2016) (67)
- Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease. (2013) (65)
- Targeted renal therapies through microbubbles and ultrasound. (2010) (65)
- Hyperglycemia Is a Major Determinant of Albumin Permeability in Diabetic Microcirculation (2007) (64)
- Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer (2016) (64)
- Novel interactions between TGF-{beta}1 actions and the 12/15-lipoxygenase pathway in mesangial cells. (2005) (62)
- The Ob protein (leptin) and the kidney. (1998) (61)
- A role for the tubular Na+-H+-exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin. (2020) (61)
- Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression (2019) (61)
- Obesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox Balance. (2016) (60)
- Potential Role of TGF-β in Diabetic Nephropathy (1998) (59)
- The Warburg Effect in Diabetic Kidney Disease. (2018) (59)
- Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy. (1995) (58)
- Diabetic nephropathy: of mice and men. (2005) (58)
- Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells. (2003) (58)
- The role of aldosteronism in causing obesity-related cardiovascular risk. (2010) (58)
- Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice (2016) (57)
- NADPH oxidase NOX1 is involved in activation of protein kinase C and premature senescence in early stage diabetic kidney. (2015) (56)
- Interactions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease. (2015) (55)
- Sodium–glucose transport: role in diabetes mellitus and potential clinical implications (2010) (55)
- Genomic strategies for diabetic nephropathy. (2003) (53)
- Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians. (2019) (52)
- Rationale and design of the Kidney Precision Medicine Project. (2021) (50)
- Beneficial Effects of AMP-Activated Protein Kinase Agonists in Kidney Ischemia-Reperfusion: Autophagy and Cellular Stress Markers (2014) (49)
- TGF-beta impairs renal autoregulation via generation of ROS. (2005) (48)
- Adiponectin effects on the kidney. (2014) (48)
- Mechanisms of kidney fibrosis and the role of antifibrotic therapies (2009) (47)
- Uncoupling of ER-mitochondrial calcium communication by transforming growth factor-beta. (2008) (45)
- Role of Reactive Oxygen Species in Hyperadrenergic Hypertension: Biochemical, Physiological, and Pharmacological Evidence From Targeted Ablation of the Chromogranin A (Chga) Gene (2010) (45)
- The Renal TGF-β System in the db/db Mouse Model of Diabetic Nephropathy (1998) (45)
- Transforming growth factor-beta: A clinical target for the treatment of diabetic nephropathy (2004) (44)
- TGF-beta in diabetic kidney disease: role of novel signaling pathways. (2000) (43)
- AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys. (2015) (42)
- Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II. (2005) (40)
- Blockade of MCU-Mediated Ca2+ Uptake Perturbs Lipid Metabolism via PP4-Dependent AMPK Dephosphorylation. (2019) (40)
- A Multimodal and Integrated Approach to Interrogate Human Kidney Biopsies with Rigor and Reproducibility: Guidelines from the Kidney Precision Medicine Project. (2020) (38)
- Stimulation of urinary TGF-beta and isoprostanes in response to hyperglycemia in humans. (2006) (37)
- TGF-β-induced Ca2+ influx involves the type III IP3 receptor and regulates actin cytoskeleton (2002) (37)
- Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake. (2007) (37)
- Mitochondrial pyruvate and fatty acid flux modulate MICU1-dependent control of MCU activity (2020) (37)
- Gut Microbial Changes in Diabetic db/db Mice and Recovery of Microbial Diversity upon Pirfenidone Treatment (2020) (37)
- Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA–T2D™ trial (2015) (36)
- Effect of Renal Tubule-Specific Knockdown of the Na+/H+ Exchanger NHE3 in Akita Diabetic Mice. (2019) (36)
- Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy. (2010) (35)
- Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study. (2020) (35)
- Role of the USF1 transcription factor in diabetic kidney disease. (2011) (34)
- Effects of dapagliflozin on urinary metabolites in people with type 2 diabetes (2019) (34)
- Tribbles homolog 3 attenuates mammalian target of rapamycin complex-2 signaling and inflammation in the diabetic kidney. (2014) (34)
- Autophagy and metabolic changes in obesity-related chronic kidney disease. (2013) (33)
- Sugar, sex, and TGF-β in diabetic nephropathy. (2012) (33)
- Myofibroblasts acquire retinoic acid-producing ability during fibroblast-to-myofibroblast transition following kidney injury. (2019) (33)
- Systems biology analysis reveals role of MDM2 in diabetic nephropathy. (2016) (32)
- Mitochondrial Dysfunction in the Diabetic Kidney. (2017) (31)
- Temporal Telomere and DNA Damage Responses in the Space Radiation Environment. (2020) (30)
- Renal dysfunction in heart failure patients: what is the evidence? (2007) (29)
- The pathogenesis of fibrosis and renal disease in scleroderma: Recent insights from glomerulosclerosis (2004) (29)
- DESI-MSI and METASPACE indicates lipid abnormalities and altered mitochondrial membrane components in diabetic renal proximal tubules (2020) (28)
- Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus (2018) (26)
- Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial. (2018) (26)
- Utility of Serum and Urinary Transforming Growth Factor-Beta Levels as Markers of Diabetic Nephropathy (2000) (25)
- Differential network enrichment analysis reveals novel lipid pathways in chronic kidney disease (2019) (25)
- Potential role of TGF-beta in diabetic nephropathy. (1998) (25)
- Antifibrotic treatment and other new strategies for improving renal outcomes. (2011) (24)
- The renal TGF-beta system in the db/db mouse model of diabetic nephropathy. (1998) (23)
- Growth arrest of a murine mesangial cell line by transforming growth factor beta 1 is associated with inhibition of mitogen-induced Ca2+ mobilization. (1995) (22)
- Obesity, immunomodulation and chronic kidney disease. (2013) (22)
- TGF-beta-induced Ca(2+) influx involves the type III IP(3) receptor and regulates actin cytoskeleton. (2002) (21)
- A reference tissue atlas for the human kidney (2021) (21)
- A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy. (2007) (21)
- Renal type I inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin-induced diabetic rats and mice. (1999) (21)
- Acid Load and Phosphorus Homeostasis in CKD. (2017) (20)
- In vivo validation and 3D visualization of broadband ultrasound molecular imaging. (2013) (19)
- Urine metabolites are associated with glomerular lesions in type 2 diabetes (2018) (18)
- Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis (2018) (18)
- Novel Aspects of Transforming Growth Factor-Beta in Diabetic Kidney Disease (2002) (17)
- AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin (2017) (17)
- Mannan-Binding Lectin in Diabetic Kidney Disease: The Impact of Mouse Genetics in a Type 1 Diabetes Model (2012) (17)
- Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects db/db mice against progression of diabetic kidney disease (2020) (16)
- Visualizing the mouse podocyte with multiphoton microscopy. (2012) (16)
- Effects of water restriction on gene expression in mouse renal medulla: identification of 3betaHSD4 as a collecting duct protein. (2006) (16)
- The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy (2017) (15)
- Regulation of inositol 1,4,5-trisphosphate receptors by transforming growth factor-beta: implications for vascular dysfunction in diabetes. (2000) (15)
- Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes (2021) (15)
- Response Surface Methodology As a New Approach for Finding Optimal MALDI Matrix Spraying Parameters for Mass Spectrometry Imaging. (2020) (14)
- Adipokines protecting CKD. (2013) (14)
- Morphine modulates migration of monocytes. (1996) (14)
- Effects of high-fat diet and losartan on renal cortical blood flow using contrast ultrasound imaging. (2013) (14)
- Elevated lipoxygenase and cytochrome P450 products predict progression of chronic kidney disease. (2018) (13)
- Role of Smad 4 on TGF-– induced extracellular matrix stimulation in mesangial cells (2010) (12)
- Renal handling of adipokines. (2006) (12)
- Ca2+ influx through the osteoclastic plasma membrane ryanodine receptor (2002) (12)
- Storage conditions of human kidney tissue sections affect spatial lipidomics analysis reproducibility. (2020) (11)
- Identification of pathognomonic purine synthesis biomarkers by metabolomic profiling of adolescents with obesity and type 2 diabetes (2020) (11)
- A Multicenter Evaluation of Blood Purification with Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19: A Preliminary Report (2021) (10)
- Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept (2019) (10)
- Fatigue characteristics on dialysis and non-dialysis days in patients with chronic kidney failure on maintenance hemodialysis (2021) (9)
- Regulation of transforming growth factor-beta1 by insulin in prediabetic African Americans. (2010) (8)
- A Multimodal and Integrated Approach to Interrogate Human Kidney Biopsies with Rigor and Reproducibility: The Kidney Precision Medicine Project (2019) (8)
- Inhibition of type I and III IP3Rs by TGF-β is associated with impaired calcium release in mesangial cells (2000) (7)
- AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat-induced kidney disease in mice. (2019) (7)
- TGF-β Inhibits Ang II-Induced MAPK p44/42 Signaling in Vascular Smooth Muscle Cells by Ang II Type 1 Receptor Downregulation (2009) (7)
- Evolutionary conservation of human ketodeoxynonulosonic acid production is independent of sialoglycan biosynthesis. (2020) (6)
- Proximal tubular epithelial insulin receptor mediates high-fat diet–induced kidney injury (2021) (6)
- Chloride channel accessory 1 integrates chloride channel activity and mTORC1 in aging‐related kidney injury (2021) (6)
- The use of neutralizing antibodies to demonstrate the role of transforming growth factor-beta and Amadori-glycated albumin as mediators of experimental diabetic kidney disease. (1996) (6)
- Enhanced Spatial Mapping of Histone Proteoforms in Human Kidney Through MALDI-MSI by High-Field UHMR-Orbitrap Detection. (2022) (6)
- Renal type I inositol 1,4,5-trisphosphate receptor is reduced in streptozotocin-induced diabetic rats and mice. (1999) (6)
- Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction (2018) (5)
- Towards Building a Smart Kidney Atlas: Network-based integration of multimodal transcriptomic, proteomic, metabolomic and imaging data in the Kidney Precision Medicine Project (2020) (5)
- Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes (2021) (5)
- Restoring mitochondrial superoxide levels with elamipretide (MTP-131) protects db/db mice against progression of diabetic kidney disease. (2020) (5)
- Quality-controlled R-loop meta-analysis reveals the characteristics of R-loop consensus regions (2021) (5)
- A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes (2020) (5)
- A metabolite-GWAS (mGWAS) approach to unveil chronic kidney disease progression. (2017) (4)
- AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat-induced kidney disease in mice[S] (2019) (4)
- Isoform- and Species-specific Control of Inositol 1,4,5-Trisphosphate (IP 3 ) Receptors by Reactive (2014) (4)
- Rapid Automated Annotation and Analysis of N-Glycan Mass Spectrometry Imaging Data Sets Using NGlycDB in METASPACE. (2021) (4)
- Branched-Chain Amino Acids Depletion during Hemodialysis Is Associated with Fatigue (2020) (4)
- Diabetic nephropathy. (2001) (4)
- Response to Comment on Sharma. Mitochondrial Hormesis and Diabetic Complications. Diabetes 2015;64:663–672 (2015) (3)
- Association of Brain-Derived Neurotrophic Factor (BDNF) Gene Snps G196A and C270T with Alzheimer’s Disease: A Meta-Analysis (2017) (3)
- 2‐D Difference In‐Gel Electrophoresis (2‐D DIGE) and Urinary Proteomics (2009) (3)
- High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study (2022) (3)
- Introduction: Systems Biology of Kidney Disease. (2018) (3)
- Myeloperoxidase Activity and Oxidized Amino Acids as Biomarkers in Chronic Kidney Disease and Coronary Artery Disease (2017) (3)
- mGWAS: next generation genetic prediction in kidney disease (2020) (3)
- Reactive Oxygen Species and Chronic Kidney Disease (2014) (2)
- Toward individual glomerular phenotyping: advent of precision medicine in kidney biopsies. (2018) (2)
- Hemoglobin A1c and Survival in Maintenance Hemodialysis Patients (2007) (2)
- Urine metabolites are associated with glomerular lesions in type 2 diabetes (2018) (2)
- Inhibition of type I and III IP(3)Rs by TGF-beta is associated with impaired calcium release in mesangial cells. (2000) (2)
- Natural History and Diagnosis of Diabetic Kidney Disease (2012) (2)
- A new drug combination significantly reduces kidney tumor progression in kidney mouse model (2018) (2)
- Tell-tale signs of perturbed podocytes. (2014) (2)
- The Protective Role of Sestrin2 in High Fat Diet-Induced Nephropathy (2020) (2)
- Comparative genomics and diversity of SARS-CoV-2 suggest potential regional virulence (2020) (2)
- Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes. (2022) (2)
- Metabolomic and Genomic Markers of Atherosclerosis as Related to Oxidative Stress, Inflammation, and Vascular Function in Twin Astronauts (2016) (2)
- An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models (2021) (2)
- Assessment of fatigue in hemodialysis patients: Performance of the Brief Fatigue Inventory. (2020) (2)
- Controlled Humidity Levels for Fine Spatial Detail Information in Enzyme-Assisted N-Glycan MALDI MSI. (2022) (2)
- CHAPTER 78 – Pathophysiology and Pathogenesis of Diabetic Nephropathy (2008) (2)
- Hydroxyurea as an alternative therapy for psoriasis Hydroxyurea as an alternative therapy for psoriasis Hydroxyurea as an alternative therapy for psoriasis Hydroxyurea as an alternative therapy for psoriasis Hydroxyurea as an alternative therapy for psoriasis (2004) (1)
- Chronic Kidney Disease and Fibrosis Role of Nox 2 in diabetic kidney disease (2013) (1)
- Exploration and analysis of R-loop mapping data with RLBase (2021) (1)
- Role of Matrix assisted Laser Desorption/ionization (MALDI)- Mass Spectrometry Imaging (MSI): A novel tool to study bioenergetic signature in kidney cancer (2022) (1)
- Diabetes: Statins for microvascular complications—all but the kidney (2014) (1)
- Global Health Training Opportunities in North American Nephrology Fellowships (2019) (1)
- Novel systems biology insights using antifibrotic approaches for diabetic kidney disease (2010) (1)
- Role of Mitochondria in the Regulation of Kidney Function and Metabolism in Type 2 Diabetes (2019) (1)
- Therapeutic Potential of AICAR in Attenuating Obesity‐Induced Metabolic, Liver and Kidney Disease (2016) (1)
- ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap (2016) (1)
- Treatment-Induced Changes in Plasma Adiponectin Do Not Reduce Urinary Albumin Excretion in the Diabetes Prevention Program Cohort (2015) (1)
- SAT-LB048 Identification of Pathognomonic Purine Synthesis Biomarkers by Metabolomic Profiling of Youth with Type 2 Diabetes (2019) (0)
- RLSuite: An integrative R-loop bioinformatics framework (2022) (0)
- Predictive Biomarkers in Nephrology Around the Corner (2019) (0)
- Programming Normal Renal Development and Modeling Disease Pathogenesis Role of the USF 1 transcription factor in diabetic kidney disease (2011) (0)
- Tissue Preparation for Spatial Metabolomics v1 (2020) (0)
- University of Groningen A Genome-Wide Methylation Study on Essential Hypertension in Young African American Males (2012) (0)
- Kidney time-activity curves of 99mTc-tilmanocept are altered in diabetic mice (2019) (0)
- A role for organic anion transporters OAT1 and OAT3 in renal secretion of creatinine (2011) (0)
- Optical Image Collection v1 (2020) (0)
- Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway (2016) (0)
- Nephrology Training: Time to Revisit Integrative Physiology (2020) (0)
- Applications of Bioinformatics in Era of Genomics and Proteomics: Future Prospect and Challenges (2017) (0)
- Large-scale, three-dimensional tissue cytometry of the human kidney: a complete and accessible pipeline. (2021) (0)
- Renal imaging via receptor-mediated binding of radiolabeled tilmanocept to mesangial cells of healthy rats (2014) (0)
- Examining the Individual Response to a Low-Sodium Diet in Patients with Hypertension: Protocol for a Pilot Randomized Controlled Trial (2023) (0)
- Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice (2016) (0)
- Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometric Imaging (MALDI-MSI) v1 (2020) (0)
- Tryptophan metabolites and anemia in patients with diabetic kidney disease. (2023) (0)
- Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS) for Bulk Metabolomics (2020) (0)
- 332 Role of Kynurenine/Tryptophan Ratio in Kidney-Lung crosstalk in two porcine trauma-induced multi-organ injury models (2023) (0)
- Control of IP 3 receptors by reactive oxygen species 1 Isoform-and species-specific control of IP 3 receptors by reactive oxygen species * (2017) (0)
- Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS) for Bulk Metabolomics v1 (2020) (0)
- The Jefferson Center for Diabetic Kidney Disease (2000) (0)
- Empagliflozin reduces renal lipotoxicity in experimental Alport syndrome (2022) (0)
- Calcium phosphate crystals observed during atherosclerosis have a cytotoxic effect that results in loss of calcium homeostasis (2016) (0)
- Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome. (2023) (0)
- 18 - Empagliflozin Is Associated With Increased Plasma Lipid Metabolites in Type 1 Diabetes (2020) (0)
- Effects of high fat diet and losartan on renal cortical blood flow using contrast (2013) (0)
- Effects of high fat diet and losartan on renal cortical blood flow using contrast 2 ultrasound imaging (2013) (0)
- Pro-resolving lipids attenuate adipose inflammation in obese patients (2016) (0)
- CALL FOR PAPERS Programming Normal Renal Development and Modeling Disease Pathogenesis Role of the USF1 transcription factor in diabetic kidney disease (2011) (0)
- Structural and Functional Consequences of Streptozotocin-Induced Diabetes on the Kidney (2018) (0)
- Chapter 5 TGF-ß inhibits Ang II-induced MAPK p 44 / 42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation (2009) (0)
- PowerPoint Slides for: Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer (2016) (0)
- Contents Vol. 128, 2014 (2015) (0)
- DESI-MSI and METASPACE indicates lipid abnormalities and altered mitochondrial membrane components in diabetic renal proximal tubules (2020) (0)
- Lipoxin A Attenuates Obe 4 sity-Induced Adipose Inflammation and Associated Liver and Kidney Disease Graphical (0)
- CALL FOR PAPERS Chronic Kidney Disease and Fibrosis Role of Nox2 in diabetic kidney disease (2013) (0)
- Visualizing the podocyte with multiphoton microscopy (2012) (0)
- Calcium phosphate crystals found in atherosclerotic plaques induce cytotoxic effects via loss of cellular calcium homeostasis. (2016) (0)
- Renal Hypoxia Interactions between HIF-1 and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease (2015) (0)
- Chapter 6 Antibody mediated targeting of microbubbles to the vasculature of diabetic kidneys (2009) (0)
- Gene Expression Profiling in the Investigation of Diabetic Nephropathy (2006) (0)
- The pathological changes in the glomerulus with diabetic nephropathy (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kumar Sharma?
Kumar Sharma is affiliated with the following schools:
